ASCO in ActionASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.

To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.

Tune in to ASCO's new ASCO in Action podcast series, providing analysis and commentary on cancer policy and practice issues, available through iTunes or Google Play.

Showing results for Reimbursement

February 15, 2018

On February 12, the White House released its Fiscal Year (FY) 2019 budget proposal, which included several provisions and budget changes of interest to the cancer community. While the proposal is not binding, it does provide a view into some of the Administration’s goals and budget priorities for the year. 

February 14, 2018

As deadlines draw near for submitting data for the 2017 Merit-based Incentives Payment System (MIPS) performance period, CMS has created a Top Ten List of things to know and do before the March deadline, along with important dates to remember.

February 12, 2018

Robin Zon, MD, FACP, FASCO, a medical oncologist at Michiana Hematology Oncology and last year’s ASCO Advocate of the Year, joined ASCO CEO Dr. Clifford Hudis this month to discuss Congressional advocacy and the role it plays in shaping cancer-related policies.

February 12, 2018

Congress passed the “Bipartisan Budget Act of 2018,” which funds the federal government through March 23, 2018, raises the federal budget caps for the next two years, and addresses several policies of importance to the cancer community.

February 9, 2018

The American Society of Clinical Oncology (ASCO) commends Congress for passing a continuing resolution that includes an important correction to the Merit-based Incentive Payment System. We are also pleased to see a budget deal that commits to at least a $2 billion funding increase for the National Institutes of Health (NIH) to reclaim America’s leadership in cancer research and continue building on our tremendous progress towards understanding, preventing, and treating cancer.

February 7, 2018

ASCO applauds a provision in the continuing resolution (CR) passed by the House of Representatives yesterday that will ensure that payment adjustments under the Merit-based Incentive Payment System (MIPS) are not applied to Medicare Part B drug reimbursement. ASCO has strongly advocated for this change since the release of a proposed Quality Payment Program rule by the Centers for Medicare and Medicaid Services in June of 2017

February 7, 2018

ASCO today released its review of leading oncology pathway vendors in the United States. "Oncology Clinical Pathways: Charting the Landscape of Pathway Providers," published in the Journal of Oncology Practice (JOP), examines the clinical pathways offered by six commercial vendors using the society's criteria for high-quality clinical pathways.

February 7, 2018

ASCO submitted comments to House Energy and Commerce Committee leadership in response to a committee report entitled, “Review of the 340B Drug Pricing Program,” which examines the program and outlines recommendations to address existing challenges. ASCO appreciates the Committee’s efforts to ensure 340B honors its original intent to address the needs of low-income, underserved, and underinsured patients.  

February 1, 2018

The Centers for Medicare & Medicaid Services (CMS) has updated its Extreme and Uncontrollable Circumstances policy for the 2017 Merit-based Incentive Payment System (MIPS) transition year to include counties affected by Hurricane Nate and the California wildfires.

January 30, 2018

ASCO is inviting all oncology practices to participate in the annual Survey of Oncology Practice Operations, which looks at the current state of business and operational issues in oncology.

January 18, 2018

ASCO and the American Society for Radiation Oncology have launched their new, joint platform for quality reporting, making it easier for oncologists to comply with federal government reporting requirements in 2018. 

January 2, 2018

ASCO submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the agency’s rule finalizing changes to the Quality Payment Program (QPP) in 2018. ASCO commends CMS for providing relief to physicians impacted by hurricanes in 2017, but urges the agency to remove Part B reimbursement from payment adjustments under the Merit-Based Incentive Payment System (MIPS) and to reconsider the weighting of ASCO quality programs in the MIPS Improvement Activities (IA) category.